PHENTERMINE

Phentermine Adverse Events Reported to the FDA Over Time

How are Phentermine adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Phentermine, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Phentermine is flagged as the suspect drug causing the adverse event.

Most Common Phentermine Adverse Events Reported to the FDA

What are the most common Phentermine adverse events reported to the FDA?

Drug Ineffective	39 (2.34%)
Cardiac Arrest	26 (1.56%)
Headache	22 (1.32%)
Completed Suicide	21 (1.26%)
Anxiety	20 (1.2%)
Dizziness	19 (1.14%)
Dyspnoea	19 (1.14%)
Myocardial Infarction	17 (1.02%)
Nausea	17 (1.02%)
Respiratory Arrest	17 (1.02%)
Insomnia	16 (.96%)
	Show More
Palpitations	15 (.9%)
Chest Pain	14 (.84%)
Feeling Abnormal	14 (.84%)
Oedema Peripheral	14 (.84%)
Blood Pressure Increased	12 (.72%)
Drug Toxicity	12 (.72%)
Fatigue	12 (.72%)
Overdose	12 (.72%)
Pain	12 (.72%)
Pulmonary Hypertension	12 (.72%)
Renal Failure Acute	12 (.72%)
Cardio-respiratory Arrest	11 (.66%)
Hypertension	11 (.66%)
Vomiting	11 (.66%)
Weight Increased	11 (.66%)
Abortion Spontaneous	10 (.6%)
Hypotension	10 (.6%)
Mitral Valve Incompetence	10 (.6%)
Ventricular Tachycardia	10 (.6%)
Confusional State	9 (.54%)
Convulsion	9 (.54%)
Depression	9 (.54%)
Drug Effect Decreased	9 (.54%)
Heart Rate Increased	9 (.54%)
Hypoaesthesia	9 (.54%)
Pulmonary Embolism	9 (.54%)
Rhabdomyolysis	9 (.54%)
Tricuspid Valve Incompetence	9 (.54%)
Ventricular Fibrillation	9 (.54%)
Cardiac Valve Disease	8 (.48%)
Colitis Ischaemic	8 (.48%)
Drug Abuse	8 (.48%)
Malaise	8 (.48%)
Mitral Valve Prolapse	8 (.48%)
Rash	8 (.48%)
Abnormal Behaviour	7 (.42%)
Alanine Aminotransferase Increased	7 (.42%)
Atrial Fibrillation	7 (.42%)
Back Pain	7 (.42%)
Bronchitis	7 (.42%)
Cerebrovascular Accident	7 (.42%)
Death	7 (.42%)
Drug Interaction	7 (.42%)
Paraesthesia	7 (.42%)
Syncope	7 (.42%)
Abdominal Pain	6 (.36%)
Abdominal Pain Upper	6 (.36%)
Aspartate Aminotransferase Increase...	6 (.36%)
Chest Discomfort	6 (.36%)
Lethargy	6 (.36%)
Loss Of Consciousness	6 (.36%)
Pain In Extremity	6 (.36%)
Panic Attack	6 (.36%)
Paranoia	6 (.36%)
Poisoning	6 (.36%)
Upper Respiratory Tract Infection	6 (.36%)
Agitation	5 (.3%)
Anger	5 (.3%)
Arthralgia	5 (.3%)
Asthenia	5 (.3%)
Calculus Urinary	5 (.3%)
Coronary Artery Disease	5 (.3%)
Diarrhoea	5 (.3%)
Gout	5 (.3%)
Impaired Driving Ability	5 (.3%)
Incorrect Dose Administered	5 (.3%)
Leukocytosis	5 (.3%)
Medication Error	5 (.3%)
Multiple Drug Overdose	5 (.3%)
Muscle Spasms	5 (.3%)
Parotitis	5 (.3%)
Psychotic Disorder	5 (.3%)
Pyrexia	5 (.3%)
Sinus Tachycardia	5 (.3%)
Vision Blurred	5 (.3%)
Weight Decreased	5 (.3%)
White Blood Cell Count Increased	5 (.3%)
Alopecia	4 (.24%)
Asthma	4 (.24%)
Cardiac Disorder	4 (.24%)
Cardiomyopathy	4 (.24%)
Cataract	4 (.24%)
Deep Vein Thrombosis	4 (.24%)
Dry Mouth	4 (.24%)
Dysarthria	4 (.24%)
Erythema	4 (.24%)
Fear	4 (.24%)
Feeling Cold	4 (.24%)
Feeling Jittery	4 (.24%)
Gastrooesophageal Reflux Disease	4 (.24%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Phentermine, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Phentermine is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Phentermine

What are the most common Phentermine adverse events reported to the FDA?

Neurological	90 (5.41%)
Cardiac Arrhythmias	85 (5.11%)
Therapeutic And Nontherapeutic Effe...	68 (4.08%)
Respiratory	54 (3.24%)
Gastrointestinal Signs	52 (3.12%)
Cardiac And Vascular Investigations	46 (2.76%)
Cardiac Valve	42 (2.52%)
Medication Errors	42 (2.52%)
Anxiety Disorders	41 (2.46%)
Infections - Pathogen Unspecified	32 (1.92%)
Epidermal And Dermal Conditions	31 (1.86%)
	Show More
Coronary Artery	29 (1.74%)
Myocardial	28 (1.68%)
Suicidal And Self-injurious Behavio...	28 (1.68%)
Muscle	26 (1.56%)
Headaches	25 (1.5%)
Musculoskeletal And Connective Tiss...	24 (1.44%)
Pulmonary Vascular	23 (1.38%)
Central Nervous System Vascular	22 (1.32%)
Cardiac Disorder Signs	21 (1.26%)
Chemical Injury And Poisoning	20 (1.2%)
Physical Examination Topics	20 (1.2%)
Hepatic And Hepatobiliary	19 (1.14%)
Sleep Disorders	18 (1.08%)
Injuries	17 (1.02%)
Psychiatric	17 (1.02%)
Decreased And Nonspecific Blood Pre...	16 (.96%)
Disturbances In Thinking	16 (.96%)
Gastrointestinal Motility And Defec...	15 (.9%)
Hepatobiliary	14 (.84%)
Renal Disorders	14 (.84%)
Seizures	14 (.84%)
Urinary Tract Signs	13 (.78%)
Deliria	12 (.72%)
Depressed Mood Disorders	12 (.72%)
Fatal Outcomes	12 (.72%)
Hematology Investigations	12 (.72%)
Movement Disorders	12 (.72%)
Vascular Hypertensive	12 (.72%)
Gastrointestinal Inflammatory Condi...	11 (.66%)
Lifestyle Issues	11 (.66%)
Mood Disorders	11 (.66%)
Personality Disorders	11 (.66%)
Abortions And Stillbirth	10 (.6%)
Appetite And General Nutritional	10 (.6%)
Vision	10 (.6%)
Administration Site Reactions	9 (.54%)
Bacterial Infectious	9 (.54%)
Joint	9 (.54%)
Mental Impairment	9 (.54%)
Product Quality Issues	9 (.54%)
Purine And Pyrimidine Metabolism	9 (.54%)
Allergic Conditions	8 (.48%)
Electrolyte And Fluid Balance Condi...	8 (.48%)
Gastrointestinal Hemorrhages	8 (.48%)
Skin Appendage Conditions	8 (.48%)
Enzyme	7 (.42%)
Eye	7 (.42%)
Menstrual Cycle And Uterine Bleedin...	7 (.42%)
Psychiatric And Behavioural Symptom...	7 (.42%)
Skin And Subcutaneous Tissue	7 (.42%)
Urolithiases	7 (.42%)
Water, Electrolyte And Mineral	7 (.42%)
White Blood Cell	7 (.42%)
Anterior Eye Structural Change, Dep...	6 (.36%)
Bone And Joint Injuries	6 (.36%)
Embolism And Thrombosis	6 (.36%)
Glucose Metabolism Disorders	6 (.36%)
Metabolic, Nutritional And Blood Ga...	6 (.36%)
Neuromuscular	6 (.36%)
Salivary Gland Conditions	6 (.36%)
Skin Vascular Abnormalities	6 (.36%)
Body Temperature Conditions	5 (.3%)
Oral Soft Tissue Conditions	5 (.3%)
Schizophrenia And Other Psychotic	5 (.3%)
Spleen, Lymphatic And Reticulendoth...	5 (.3%)
Toxicology And Therapeutic Drug Mon...	5 (.3%)
Angiedema And Urticaria	4 (.24%)
Bone And Joint Therapeutic Procedur...	4 (.24%)
Bone Disorders	4 (.24%)
Bronchial Disorders	4 (.24%)
Coagulopathies And Bleeding Diathes...	4 (.24%)
Exocrine Pancreas Conditions	4 (.24%)
Manic And Bipolar Mood Disorders	4 (.24%)
Ocular Neuromuscular	4 (.24%)
Vascular	4 (.24%)
Aneurysms And Artery Dissections	3 (.18%)
Arteriosclerosis, Stenosis, Vascula...	3 (.18%)
Autoimmune	3 (.18%)
Breast	3 (.18%)
Changes In Physical Activity	3 (.18%)
Economic And Housing Issues	3 (.18%)
Gastrointestinal Conditions	3 (.18%)
Increased Intracranial Pressure And...	3 (.18%)
Lower Respiratory Tract Disorders	3 (.18%)
Ocular Structural Change, Deposit A...	3 (.18%)
Renal And Urinary Tract Investigati...	3 (.18%)
Tongue Conditions	3 (.18%)
Vascular Inflammations	3 (.18%)
Viral Infectious	3 (.18%)
Anemias Nonhemolytic And Marrow Dep...	2 (.12%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Phentermine, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Phentermine is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.